Business
Vivet Therapeutics Presents Three Posters On Cerebrotendinous Xanthomatosis Program And Novel AAV Gene Delivery Platform At European Society Of Gene And Cell Therapy Annual Congress 2024
(MENAFN - GlobeNewsWire - Nasdaq) Vivet Therapeutics Presents Three Posters on Cerebrotendinous Xanthomatosis Program and Novel AAV Gene Delivery Platform at European Society of Gene and Cell ...
By: menafn
- Oct 22 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS